Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB
March 22, 2023Delhi, 22 March 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) called on governments and donors today to speed up access to new, shorter, safer and more effective treatments* for drug-resistant tuberculosis (DR-TB), as well as the diagnostic tests needed...
Read more
Afghanistan: The MSF hospital in Kandahar provides hope for people with TB
December 8, 2022Jawahira was referred to the Médecins Sans Frontières (MSF) tuberculosis (TB) hospital in Kandahar earlier this year from a clinic in Daikundi, central Afghanistan. “I used to visit private clinics, but instead of giving me TB medication, they usually just...
Read more
Between life and living: Patients with drug-resistant tuberculosis (DR-TB) share stories of strength, support and suffering
December 2, 2022India has the highest burden of both tuberculosis (TB) and multi-drug resistant tuberculosis (MDR-TB) based on estimates in the WHO Global TB Report 2022. The country accounts for 28 percent of the global TB burden. In its clinic in Mumbai, MSF...
Read more
Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives
October 28, 2022The World Health Organization (WHO) released today the 2022 edition of its Global Tuberculosis (TB) Report, featuring data on the TB response and trends in 215 countries and areas. Among the alarming trends from 2021, there is an increase in the estimated...
Read more
Tuberculosis: EndTB clinical trial for multidrug-resistant TB completes enrolment
October 18, 2021BOSTON/PARIS — Hundreds of patient volunteers from four continents have enrolled in a trial that aims to find safer, shorter, and effective treatments for multidrug-resistant tuberculosis (MDR-TB), an airborne, infectious disease that has grown resistant to standard medications. A group of scientists and...
Read more
Access to Medicines: Lifesaving TB medicines still out of reach for children in high-burden countries
September 3, 2021Geneva - The World Health Organization (WHO) recently released new rapid guidance recommending that children of all ages with drug-resistant tuberculosis (DR-TB) have access to all-oral treatment using the drugs bedaquiline and/or delamanid. However, adopting these new recommendations in high TB...
Read more
Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
March 24, 2021LONDON - A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more...
Read more
endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India
October 22, 2020Pune, India: Doctors Without Borders/ Médecins Sans Frontières (MSF) in collaboration with Indian Council for Medical Research (ICMR)- National AIDS Research Institute (NARI) and Department of Health Service, Government of Maharashtra is initiating two major clinical trials that aim at generating clinical evidence...
Read more
Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen
August 4, 2020New Delhi, India: Doctors Without Borders/Medecins Sans Frontieres (MSF) has welcomed the revision made by the World Health Organisation (WHO) to its tuberculosis (TB) guidelines, allowing for safe use of a treatment regimen including both bedaquiline and delamanid for drug-resistant...
Read more
5 barriers from Big Pharma preventing people getting lifesaving TB drugs
March 24, 2020Tuberculosis (TB) is not a disease of the past. Every year, 1.5 million people die of it – that’s more than 4,000 people every day. But pharma companies are not providing the SOLUTION as you might expect. Here we list...
Read more
World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen
March 24, 2020Mumbai (India) - As of February 2020, the MSF private clinic in Govandi, Mumbai has initiated 188 drug-resistant tuberculosis (DR-TB) patients on treatment regimen which includes Bedaquiline and Delamanid. Globally, an estimated 10 million people fell ill with tuberculosis (TB) in 2018...
Read more
Manipur: Working with HIV and TB patients in remote areas
January 31, 2020By Edoardo Nicolotti, Project Coordinator, Manipur After working in Nepal for several years when I got the opportunity to work in Manipur, I was really excited. In my mind, I had the impression that Manipur would be very similar to...
Read more
